Literature DB >> 15108888

Validation of a model for the study of multiple wounds in the diabetic mouse (db/db).

Stephen R Sullivan1, Robert A Underwood, Nicole S Gibran, Randall O Sigle, Marcia L Usui, William G Carter, John E Olerud.   

Abstract

The genetically diabetic db/db mouse exhibits symptoms that resemble human type 2 diabetes mellitus, demonstrates delayed wound healing, and has been used extensively as a model to study the role of therapeutic topical reagents in wound healing. The purpose of the authors' study was to validate an excisional wound model using a 6-mm biopsy punch to create four full-thickness dorsal wounds on a single db/db mouse. Factors considered in developing the db/db wound model include reproducibility of size and shape of wounds, the effect of semiocclusive dressings, comparison with littermate controls (db/-), clinical versus histologic evidence of wound closure, and cross-contamination of wounds with topically applied reagents. The size of wounds was larger, with less variation in the db/db mice (31.11 +/- 3.76 mm2) versus db/- mice (23.64 +/- 4.78 mm2). Wounds on db/db mice that were covered with a semiocclusive dressing healed significantly more slowly (mean, 27.75 days) than wounds not covered with the dressing (mean, 13 days; p < 0.001), suggesting the dressings may splint the wounds open. As expected, wounds healed more slowly on db/db mice than db/- mice (covered wounds, 27.75 days versus 11.86 days, p < 0.001; wounds not covered, 13 days versus 11.75 days, p = 0.39). Covered wounds, thought to be closed by clinical examination, were confirmed closed by histology only 62 percent of the time in the db/db and 100 percent of the time in the db/- mice. Topical application of blue histologic dye or soluble biotinylated laminin 5 to one of the four wounds did not spread locally and contaminate adjacent wounds. Multiple, uniform, 6-mm wounds in db/db mice heal in a relatively short time, decrease the number of animals needed for each study, and allow each animal to serve as its own control. The db/db diabetic mouse appears to be an excellent model of delayed wound healing, particularly for studying factors related to epithelial migration.

Entities:  

Mesh:

Year:  2004        PMID: 15108888     DOI: 10.1097/01.prs.0000105044.03230.f4

Source DB:  PubMed          Journal:  Plast Reconstr Surg        ISSN: 0032-1052            Impact factor:   4.730


  26 in total

1.  Delayed wound healing in diabetic (db/db) mice with Pseudomonas aeruginosa biofilm challenge: a model for the study of chronic wounds.

Authors:  Ge Zhao; Phillip C Hochwalt; Marcia L Usui; Robert A Underwood; Pradeep K Singh; Garth A James; Philip S Stewart; Philip Fleckman; John E Olerud
Journal:  Wound Repair Regen       Date:  2010-08-19       Impact factor: 3.617

2.  Phosphorylation of connexin 43 at MAPK, PKC or CK1 sites each distinctly alter the kinetics of epidermal wound repair.

Authors:  Kristin J Lastwika; Clarence A Dunn; Joell L Solan; Paul D Lampe
Journal:  J Cell Sci       Date:  2019-09-23       Impact factor: 5.285

3.  Heparin-binding domain of fibrin(ogen) binds growth factors and promotes tissue repair when incorporated within a synthetic matrix.

Authors:  Mikaël M Martino; Priscilla S Briquez; Adrian Ranga; Matthias P Lutolf; Jeffrey A Hubbell
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-04       Impact factor: 11.205

4.  The heparin binding domain of von Willebrand factor binds to growth factors and promotes angiogenesis in wound healing.

Authors:  Jun Ishihara; Ako Ishihara; Richard D Starke; Claire R Peghaire; Koval E Smith; Thomas A J McKinnon; Yoji Tabata; Koichi Sasaki; Michael J V White; Kazuto Fukunaga; Mike A Laffan; Matthias P Lutolf; Anna M Randi; Jeffrey A Hubbell
Journal:  Blood       Date:  2019-04-11       Impact factor: 22.113

Review 5.  What's on the Outside Matters: The Role of the Extracellular Polymeric Substance of Gram-negative Biofilms in Evading Host Immunity and as a Target for Therapeutic Intervention.

Authors:  John S Gunn; Lauren O Bakaletz; Daniel J Wozniak
Journal:  J Biol Chem       Date:  2016-04-21       Impact factor: 5.157

6.  A chemical biological strategy to facilitate diabetic wound healing.

Authors:  Major Gooyit; Zhihong Peng; William R Wolter; Hualiang Pi; Derong Ding; Dusan Hesek; Mijoon Lee; Bill Boggess; Matthew M Champion; Mark A Suckow; Shahriar Mobashery; Mayland Chang
Journal:  ACS Chem Biol       Date:  2013-09-26       Impact factor: 5.100

7.  Blockade of TSP1-dependent TGF-β activity reduces renal injury and proteinuria in a murine model of diabetic nephropathy.

Authors:  Ailing Lu; Mi Miao; Trenton R Schoeb; Anupam Agarwal; Joanne E Murphy-Ullrich
Journal:  Am J Pathol       Date:  2011-06       Impact factor: 4.307

8.  Topical application of laminin-332 to diabetic mouse wounds.

Authors:  Stephen R Sullivan; Robert A Underwood; Randall O Sigle; Yuko Fukano; Lara A Muffley; Marcia L Usui; Nicole S Gibran; Marcos A Antezana; William G Carter; John E Olerud
Journal:  J Dermatol Sci       Date:  2007-08-24       Impact factor: 4.563

9.  Macrophage dysfunction impairs resolution of inflammation in the wounds of diabetic mice.

Authors:  Savita Khanna; Sabyasachi Biswas; Yingli Shang; Eric Collard; Ali Azad; Courtney Kauh; Vineet Bhasker; Gayle M Gordillo; Chandan K Sen; Sashwati Roy
Journal:  PLoS One       Date:  2010-03-04       Impact factor: 3.240

10.  This paper is the winner of an SFB Award in the Hospital Intern, Residency category: Peptide biomaterials raising adaptive immune responses in wound healing contexts.

Authors:  Yalini Vigneswaran; Huifang Han; Roberto De Loera; Yi Wen; Xing Zhang; Tao Sun; Carolina Mora-Solano; Joel H Collier
Journal:  J Biomed Mater Res A       Date:  2016-05-26       Impact factor: 4.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.